ÂÜÀòÂÒÂ×

J. Matthew Hutzler, Ph.D. has extensive work experience in the pharmaceutical industry. J. Matthew is currently the Executive Director of Scientific Engagement (Drug Discovery) at Inotiv, where they focus on providing high-quality data and solutions for drug discovery programs. Prior to this role, they served as the Senior Director of Drug Discovery Program Development at Inotiv, where they delivered comprehensive nonclinical and analytical services for clients.

Before joining Inotiv, Dr. Hutzler worked at Q² Solutions as the Director of ADME Services. J. Matthew was responsible for overseeing the department and ensuring the successful execution of ADME studies.

At Quintiles, Dr. Hutzler held two roles. J. Matthew first served as the Director of In Vitro Metabolism, where they guided the DMPK strategy to support medicinal chemistry and discovery teams. J. Matthew then worked as a Research Investigator before joining Boehringer Ingelheim Pharmaceuticals.

At Boehringer Ingelheim Pharmaceuticals, Dr. Hutzler was a Senior Principal Scientist. J. Matthew played a crucial role in driving the drug metabolism and pharmacokinetic strategy for drug discovery projects in cardiometabolic and inflammatory disease therapeutic areas. J. Matthew had direct reports and mentored senior-level associates in the DMPK project discipline.

Before joining Boehringer Ingelheim Pharmaceuticals, Dr. Hutzler worked at Pfizer as a Senior Principal Scientist, contributing to various projects. J. Matthew also gained postdoctoral research experience at Pharmacia (former Upjohn Company).

Overall, Dr. J. Matthew Hutzler's work experience demonstrates their expertise in drug discovery, nonclinical services, ADME studies, and DMPK strategy development.

J. Matthew Hutzler, Ph.D. earned their Ph.D. in Drug Metabolism/Pharmacokinetics from West Virginia University, from 1997 to 2001.